This review highlights the increasing prevalence of cardiovascular risk factors in aging haemophilia patients and summarizes current insights on managing conditions like atrial fibrillation and coronary ischaemia in this population.
Raises awareness of rising CVD risk in aging haemophilia; leaves open optimal management strategies.
With the aging of the haemophilia population, age related comorbidities become more and more a medical issue. Managing haemophilia patients with cardiovascular disease is a difficult task for many haemophilia-treating physicians. Over the years, insights on prevalence, risk factors and management of cardiovascular disease in haemophilia have improved substantially. It is now recognised that many risk factors, such as hypertension and overweight, occur quite frequently in patients with haemophilia. Several new insights in anticoagulation management of atrial fibrillation and coronary ischaemia in haemophilia have been suggested. This review provides an general overview of the current knowledge of these topics in literature.
No takes yet. Share an insight, caveat, or question.
Voskuil et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: